Dinter, Franziska
Burdukiewicz, Michał
Schierack, Peter
Lehmann, Werner
Nestler, Jörg
Dame, Gregory
Rödiger, Stefan http://orcid.org/0000-0002-1441-6512
Funding for this research was provided by:
Ministerium für Wissenschaft, Forschung und Kultur (06-GeCa:H228-05/002/004)
Article History
Received: 11 June 2019
Revised: 30 September 2019
Accepted: 8 October 2019
First Online: 23 November 2019
Compliance with ethical standards
:
: Werner Lehmann has a management role in and is a shareholder of attomol GmbH. This company is a diagnostic manufacturer. Joerg Nestler is managing director and shareholder of BiFlow Systems GmbH. All other authors declare that they have no competing financial and nonfinancial interests.The studies on blood material (serum) have been granted by the ethics committee of the Brandenburg University of Technology (BTU) Cottbus-Senftenberg, Cottbus, Germany, (Ethikkommissionssatzung BTU, document number EK2018—3) and were conducted in accordance with the Helsinki Declaration of 1964 (revised 2008). The blood donor gave a written informed consent.